Alternatives to Apimeds Pharmaceuticals
Apimeds Pharmaceuticals is a Pharmaceuticals tool: pharmaceutical company focused on merger and financing activities. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
Apimeds Pharmaceuticals profileMore Pharmaceuticals alternatives
The 20 closest Pharmaceuticals companies to Apimeds Pharmaceuticals
- Website
PCI Pharma Services57PharmaceuticalsPhiladelphia, USA$63.0MA leading global contract development and manufacturing organization (CDMO) for innovative biologic and small molecule therapies.
- Website
Advanced Accelerator Applications50PharmaceuticalsSaint-Genis-Pouilly, France$56.4MDevelops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.
- Website
Azurity Pharmaceuticals49PharmaceuticalsWoburn, United States$1.1BAzurity Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing high-quality, affordable liquid medications.
- Website
Ethypharm58PharmaceuticalsSaint-Cloud, France$557KInternational specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website VEVertice Pharma, LLC49PharmaceuticalsNew Providence, United States$300.0M
Pharma company
- JUJuno Therapeutics66BiotechnologySeattle, United States$316.7M
Biotechnology company focused on developing cancer immunotherapies.
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- Website
Elicit62Artificial IntelligenceOakland, United States$31.0MAI-powered research assistant for scientific literature review and data extraction.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Seaport Therapeutics62BiotechnologyCambridge, USA$340.0MDeveloping novel therapeutics to restore gut lymphatic function.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- CRCreate Medicines60BiotechnologyCambridge, USA$122.0M
Developing in vivo immunotherapies for autoimmune diseases and cancer.
- Website
Algorithmiq60Quantum ComputingHelsinki, Finland$38.1MQuantum software company enabling breakthroughs in chemistry, materials science, and life sciences.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Supernus Pharmaceuticals60BiotechnologyRockville, United States$17.5MBiopharmaceutical company developing and commercializing CNS disease treatments.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
Showing the 20 closest matches. See the rest on the Apimeds Pharmaceuticals profile.